154 related articles for article (PubMed ID: 11555573)
1. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.
Minaguchi T; Yoshikawa H; Oda K; Ishino T; Yasugi T; Onda T; Nakagawa S; Matsumoto K; Kawana K; Taketani Y
Clin Cancer Res; 2001 Sep; 7(9):2636-42. PubMed ID: 11555573
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
4. Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability.
Cohn DE; Basil JB; Venegoni AR; Mutch DG; Rader JS; Herzog TJ; Gersell DJ; Goodfellow PJ
Gynecol Oncol; 2000 Oct; 79(1):101-6. PubMed ID: 11006040
[TBL] [Abstract][Full Text] [Related]
5. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
[TBL] [Abstract][Full Text] [Related]
6. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
8. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
[TBL] [Abstract][Full Text] [Related]
9. PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2004 May; 11(5):1011-5. PubMed ID: 15069540
[TBL] [Abstract][Full Text] [Related]
10. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
Xu B; Yao Q; Dai SZ
Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
[TBL] [Abstract][Full Text] [Related]
11. The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.
Konopka B; Janiec-Jankowska A; Paszko Z; Goluda M
J Cancer Res Clin Oncol; 2004 Feb; 130(2):114-21. PubMed ID: 14663583
[TBL] [Abstract][Full Text] [Related]
12. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
[TBL] [Abstract][Full Text] [Related]
13. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.
Bussaglia E; del Rio E; Matias-Guiu X; Prat J
Hum Pathol; 2000 Mar; 31(3):312-7. PubMed ID: 10746673
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
15. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
[TBL] [Abstract][Full Text] [Related]
16. PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.
Kanamori Y; Kigawa J; Itamochi H; Sultana H; Suzuki M; Ohwada M; Kamura T; Sugiyama T; Kikuchi Y; Kita T; Fujiwara K; Terakawa N
Int J Cancer; 2002 Aug; 100(6):686-9. PubMed ID: 12209607
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy.
Harima Y; Sawada S; Nagata K; Sougawa M; Ostapenko V; Ohnishi T
Int J Oncol; 2001 Mar; 18(3):493-7. PubMed ID: 11179477
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
[TBL] [Abstract][Full Text] [Related]
19. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
20. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.
Maxwell GL; Risinger JI; Hayes KA; Alvarez AA; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 2000 Aug; 6(8):2999-3005. PubMed ID: 10955777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]